Host: Susan Dolan, RN, JD

Guest: Brian Carter, MD

Dr. Brian Carter, professor of pediatrics in the division of neonatology at Vanderbilt's Children's Hospital in Nashville, Tennessee, discusses the special care newborn with host Susan Dolan.

Host: Bruce Bloom, DDS, JD

Guest: Denise L. Faustman, MD

Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research may be applicable to other autoimmune diseases such as lupus.

Host: Bruce Bloom, DDS, JD

Guest: Denise L. Faustman, MD

Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug cure.

Host: Mark Nolan Hill, MD

Guest: Mark Kirk, JD

Congressman Mark Kirk, vice chair of the congressional diabetes caucus speaks with host Dr. Mark Nolan Hill both about stem cell research and the challenging problem of solving the diabetes epidemic.

Host: Danny Petrasek, MD, PhD

Guest: Ronald Wilder, MD, PhD

How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.

Host: Danny Petrasek, MD, PhD

Guest: Ronald Wilder, MD, PhD

How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.

Host: Mark Nolan Hill, MD

Guest: Mark Kirk, JD

As a veteran himself and a congressman, Mark Kirk works tirelessly to improve and expand healthcare resources for our veterans. What new healthcare initiatives are underway to serve the needs of the Unites States veterans?

Host: Mark Nolan Hill, MD

Guest: Mark Kirk, JD

In this segment Congressman Mark Kirk speaks to host Dr. Mark Nolan Hill about medical malpractice as a contributor to the high costs of healthcare. They then go on to discuss the idea of a Government Controlled Health Plan and why this would not be an ideal solution to US healthcare reform.

Host: Larry Kaskel, MD

Guest: Howard Hodis, MD

What is the latest thinking about hormone replacement therapy? Join Dr. Larry Kaskel in an interview with Dr. Howard Hodis about some recent studies about ERT and cardiovascular health.

Host: Larry Kaskel, MD

Guest: Howard Hodis, MD

Does the timing of a woman’s hormone replacement therapy (HRT) impact her risk for coronary calcification? Howard N. Hodis, MD, director of the Atherosclerosis Research Unit at the University of Southern California, reviews the data on this issue and others associated with HRT.